These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 15679290)
1. A new selective aldosterone antagonist. Inspra's role in hypertension and post-MI heart failure. Ostrenga A; Pitcock J; Pitcock M Adv Nurse Pract; 2005 Jan; 13(1):34-7. PubMed ID: 15679290 [No Abstract] [Full Text] [Related]
2. Eplerenone: a selective aldosterone receptor antagonist for hypertension and heart failure. Moore TD; Nawarskas JJ; Anderson JR Heart Dis; 2003; 5(5):354-63. PubMed ID: 14503934 [TBL] [Abstract][Full Text] [Related]
3. Aldosterone antagonists: a new treatment option for patients with post-myocardial infarction heart failure. Ajani AE; Marwick TH; Krum H Cardiovasc Revasc Med; 2006; 7(4):234-6. PubMed ID: 17174870 [TBL] [Abstract][Full Text] [Related]
5. [Selective aldosterone blocker for hypertension and heart failure. Better tolerance than previous drugs]. MMW Fortschr Med; 2002 Sep; 144(39):50. PubMed ID: 12422691 [No Abstract] [Full Text] [Related]
6. Role of the selective aldosterone receptor blockers in arterial hypertension. Sierra C; Ruilope LM J Renin Angiotensin Aldosterone Syst; 2004 Mar; 5(1):23-5. PubMed ID: 15136969 [TBL] [Abstract][Full Text] [Related]
7. Aldosterone blockade in patients with systolic left ventricular dysfunction. Pitt B Circulation; 2003 Oct; 108(15):1790-4. PubMed ID: 14557343 [No Abstract] [Full Text] [Related]
8. More hope for heart failure. Findings suggest expanded use of aldosterone-blockers. Aaronson K Health News; 2003 May; 9(5):4. PubMed ID: 12739453 [No Abstract] [Full Text] [Related]
11. [Therapy of heart failure after myocardial infarction. With eplerenone a new course]. MMW Fortschr Med; 2004 Oct; 146(43):58-9. PubMed ID: 15559524 [No Abstract] [Full Text] [Related]
12. Cost-effectiveness analysis of aldosterone blockade with eplerenone in patients with heart failure after acute myocardial infarction in the French context: the EPHESUS study. de Pouvourville G; Solesse A; Beillat M Arch Cardiovasc Dis; 2008 Sep; 101(9):515-21. PubMed ID: 19041835 [TBL] [Abstract][Full Text] [Related]
18. [Aldosterone antagonists in coronary insufficiency]. Osswald H Med Klin; 1978 Jan; 73(3):84-8. PubMed ID: 622061 [No Abstract] [Full Text] [Related]
19. Eplerenone in the treatment of chronic heart failure. Krum H; Liew D Expert Rev Cardiovasc Ther; 2004 May; 2(3):315-20. PubMed ID: 15151479 [TBL] [Abstract][Full Text] [Related]
20. The role of aldosterone receptor blockade in the management of cardiovascular disease. Liew D; Krum H Curr Opin Investig Drugs; 2002 Oct; 3(10):1468-73. PubMed ID: 12431020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]